# Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

> **NCT01371695** · — · UNKNOWN · sponsor: **Onconix, Inc** · enrollment: 60 (actual)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia II
- Cervical Intraepithelial Neoplasia III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01371695
- **Lead sponsor:** Onconix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2013-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371695, "Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01371695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*